Adrian Hunt

492 total citations
16 papers, 187 citations indexed

About

Adrian Hunt is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Adrian Hunt has authored 16 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Adrian Hunt's work include Retinal Diseases and Treatments (15 papers), Retinal and Optic Conditions (12 papers) and Retinal Imaging and Analysis (10 papers). Adrian Hunt is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Retinal and Optic Conditions (12 papers) and Retinal Imaging and Analysis (10 papers). Adrian Hunt collaborates with scholars based in Australia, Switzerland and France. Adrian Hunt's co-authors include Mark C. Gillies, Vuong Nguyen, Daniel Barthelmes, Hemal Mehta, Samantha Fraser‐Bell, Pierre‐Henry Gabrielle, Jennifer Arnold, Stephanie Young, Robyn H. Guymer and Catherine Creuzot‐Garcher and has published in prestigious journals such as Scientific Reports, Ophthalmology and British Journal of Ophthalmology.

In The Last Decade

Adrian Hunt

14 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian Hunt Australia	7	168	126	19	15	12	16	187
Abhidnya Surve India	7	111 0.7×	80 0.6×	10 0.5×	16 1.1×	13 1.1×	34	173
Yiye Chen China	6	111 0.7×	104 0.8×	11 0.6×	26 1.7×	14 1.2×	15	141
Turner D. Wibbelsman United States	11	319 1.9×	234 1.9×	16 0.8×	17 1.1×	6 0.5×	31	362
Nikolaos Dervenis Greece	9	202 1.2×	181 1.4×	10 0.5×	17 1.1×	3 0.3×	22	233
Ella H. Leung United States	11	236 1.4×	184 1.5×	25 1.3×	57 3.8×	5 0.4×	37	323
Sami Al-Shahwan Saudi Arabia	10	287 1.7×	188 1.5×	6 0.3×	24 1.6×	5 0.4×	27	330
Raouf Gaber Egypt	10	249 1.5×	226 1.8×	24 1.3×	41 2.7×	16 1.3×	20	309
Rita Serra Italy	9	212 1.3×	178 1.4×	12 0.6×	23 1.5×	2 0.2×	32	261
Rashim Mannan India	10	172 1.0×	187 1.5×	8 0.4×	14 0.9×	3 0.3×	22	257
Prut Hanutsaha Thailand	9	265 1.6×	234 1.9×	24 1.3×	16 1.1×	2 0.2×	16	323

Countries citing papers authored by Adrian Hunt

Since Specialization

Citations

This map shows the geographic impact of Adrian Hunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Hunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Hunt more than expected).

Fields of papers citing papers by Adrian Hunt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Hunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Hunt. The network helps show where Adrian Hunt may publish in the future.

Co-authorship network of co-authors of Adrian Hunt

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Hunt. A scholar is included among the top collaborators of Adrian Hunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Hunt. Adrian Hunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hunt, Adrian, Yohei Hashimoto, Stephanie Young, et al.. (2025). Outcomes After Switching to Faricimab in Neovascular Age‐Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry. Clinical and Experimental Ophthalmology. 53(9). 1156–1167. 1 indexed citations

Hashimoto, Yohei, Alessandro Invernizzi, Pierre‐Henry Gabrielle, et al.. (2024). Outliers of Treatment Frequency in Retinal Vein Occlusion: 24‐Month Comparative Analysis of Fight Retinal Blindness! Practitioners. Clinical and Experimental Ophthalmology. 53(4). 409–420.

Nguyen, Vuong, Adrian Hunt, Mark C. Gillies, et al.. (2024). European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice. Ophthalmology Retina. 8(6). 527–536. 6 indexed citations

Hunt, Adrian, Carolina Arruabarrena, Hemal Mehta, et al.. (2024). Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry. Scientific Reports. 14(1). 6122–6122. 1 indexed citations

Hashimoto, Yohei, Adrian Hunt, Gayatri Banerjee, et al.. (2024). Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy. British Journal of Ophthalmology. 109(5). 606–613.

Hunt, Adrian, Vuong Nguyen, S. Bhandari, et al.. (2022). Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF. Ophthalmology Retina. 7(4). 338–345. 6 indexed citations

Bhandari, S., Vuong Nguyen, Adrian Hunt, et al.. (2022). Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion. Eye. 37(6). 1145–1154. 6 indexed citations

Hunt, Adrian, Vuong Nguyen, Jennifer Arnold, et al.. (2022). Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry. British Journal of Ophthalmology. 107(6). 842–848. 4 indexed citations

Nguyen, Vuong, Adrian Hunt, Hemal Mehta, et al.. (2022). Characterization of Poor Visual Outcomes of Diabetic Macular Edema: The Fight Retinal Blindness! Project. Ophthalmology Retina. 6(7). 540–547. 4 indexed citations

10.

Hunt, Adrian, Vuong Nguyen, Samantha Fraser‐Bell, et al.. (2022). One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion. Clinical and Experimental Ophthalmology. 50(9). 1038–1046. 3 indexed citations

11.

Hunt, Adrian, Vuong Nguyen, Catherine Creuzot‐Garcher, et al.. (2021). Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry. British Journal of Ophthalmology. 106(8). bjophthalmol–2020. 13 indexed citations

12.

Hunt, Adrian, Vuong Nguyen, Hemal Mehta, et al.. (2021). 12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry. Acta Ophthalmologica. 100(4). e920–e927. 9 indexed citations

13.

Gabrielle, Pierre‐Henry, Vuong Nguyen, Benjamin Wolff, et al.. (2020). Intraocular Pressure Changes and Vascular Endothelial Growth Factor Inhibitor Use in Various Retinal Diseases: Long-Term Outcomes in Routine Clinical Practice. Ophthalmology Retina. 4(9). 861–870. 14 indexed citations

14.

Nguyen, Vuong, et al.. (2020). A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion. Eye. 34(10). 1770–1796. 32 indexed citations

15.

Nguyen, Vuong, Vincent Daïen, Robyn H. Guymer, et al.. (2018). Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration. Ophthalmology. 126(1). 64–74. 24 indexed citations

16.

Hunt, Adrian. (2005). Outcomes in persistent hyperplastic primary vitreous. British Journal of Ophthalmology. 89(7). 859–863. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact